77 studies found for:    "Patent ductus arteriosus"
Show Display Options
RSS Create an RSS feed from your search for:
"Patent ductus arteriosus"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated An Escalating Dose Indomethacin for the Treatment of Persistent Patent Ductus Arteriosus (PDA) In Preterm Infants
Condition: Patent Ductus Arteriosus
Intervention: Drug: Indomethacin
2 Recruiting Early Ibuprofen Treatment of Patent Ductus Arteriosus (PDA) in Premature Infants (TRIOCAPI)
Condition: Patent Ductus Arteriosus
Interventions: Drug: Ibuprofen;   Drug: Placebo
3 Unknown  Treating the Resistant Patent Ductus Arteriosus (PDA)
Condition: Patent Ductus Arteriosus
Interventions: Drug: Indomethacin;   Drug: Pentoxifylline
4 Completed Echocardiographically Guided Versus Standard Ibuprofen Treatment for Patent Ductus Arteriosus
Condition: Patent Ductus Arteriosus
Interventions: Drug: Ibuprofen EchoG;   Drug: Standard ibuprofen treatment
5 Not yet recruiting IV Acetaminophen and Patent Ductus Arteriosus
Condition: Patent Ductus Arteriosus
Interventions: Drug: Acetaminophen;   Drug: Ibuprofen
6 Unknown  Paracetamol and Patent Ductus Arteriosus (PDA)
Condition: Patent Ductus Arteriosus
Interventions: Drug: Paracetamol;   Drug: NSAID;   Drug: D5W
7 Completed Comparison of 2 Different Indomethacin Dosing Protocols to Treat Infants Delivered at <28 Weeks Gestation With a Persistent Patent Ductus Arteriosus
Condition: Patent Ductus Arteriosus
Intervention: Drug: indomethacin (two different dosing regimens)
8 Completed Closure of Patent Ductus Arteriosus With Indomethacin or Ibuprofen in Extreme Low Birth Weight Infants
Condition: Patent Ductus Arteriosus
Intervention: Drug: Ibuprofen
9 Completed Timing for the Medical Treatment of Patent Ductus Arteriosus in Preterm Infants
Condition: Patent Ductus Arteriosus
Intervention:
10 Recruiting Near Infrared Spectroscopy to Determine Patent Ductus Arteriosus Closure
Condition: Patent Ductus Arteriosus
Intervention: Device: near infrared spectroscopy
11 Completed Safety and Effectiveness Study With a New PDA Occluder for Closure of Patent Ductus Arteriosus
Condition: Patent Ductus Arteriosus
Intervention: Device: Occlutech PDA occluder
12 Not yet recruiting International Experience in Timing And Choices for Ductal Closure in Patent Ductus Arteriosus:INTERPDA Trial
Condition: Patent Ductus Arteriosus
Intervention: Device: Echocardiography
13 Recruiting Platelet Transfusion for Treatment of Patent Ductus Arteriosus in Thrombocytopenic Preterm Neonates
Condition: Patent Ductus Arteriosus
Interventions: Biological: Liberal platelet transfusion;   Biological: Restrictive platelet transfusion;   Drug: Paracetamol;   Drug: Ibuprofen
14 Completed Nitric Oxide, Endothelin-1, and the Patency of Ductus Arteriosus in Preterm Infants
Condition: Patent Ductus Arteriosus
Intervention:
15 Completed Comparative Study of Efficacy and Safety of Oral Ibuprofen and Intravenous Ibuprofen in Closure of Patent Ductus Arteriosus in Very Low Birth Weight Infants
Condition: Patent Ductus Arteriosus
Interventions: Drug: oral ibuprofen;   Drug: intravenous ibuprofen
16 Completed Influence of Treatment for Patent Ductus Arteriosus on Cerebral Oxygenation in Preterm Infants
Conditions: Prematurity of Fetus;   Patent Ductus Arteriosus
Interventions: Drug: Indomethacin;   Procedure: Surgical Ligation;   Drug: Ibuprofen
17 Completed High-dose Ibuprofen for Patent Ductus Arteriosus (PDA) in Preterm Infant
Condition: Ductus Arteriosus, Patent
Intervention: Drug: Ibuprofen
18 Active, not recruiting
Has Results
AMPLATZER Duct Occluder II Clinical Study
Condition: Patent Ductus Arteriosus
Intervention: Device: AMPLATZER Duct Occluder II
19 Not yet recruiting Adding Paracetamol to Ibuprofen for Treatment of Patent Ductus Arteriosus in Preterm Infants
Condition: Hemodynamically Significant Patent Ductus Arteriosus in Preterm Infants
Interventions: Drug: Paracetamol;   Drug: Placebo
20 Completed
Has Results
Closure Of Patent Ductus Arteriosus With the AMPLATZER Duct Occluder the AMPLATZER® Duct Occluder
Condition: Patent Ductus Arteriosus (PDA)
Interventions: Device: Device closure with AMPLATZER Duct Occluder;   Other: Objective Performance Criteria

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.